CRISPR/Cas9NKG2DCAR-T

Cristina Aparicio1,2, Mónica Queipo1, Marina Belver1

  • 1Unit of Excellence Institute of Biomedicine and Molecular Genetics of Valladolid (IBGM), Higher Council for Scientific Research (CSIC)-University of Valladolid (UVA), 47003 Valladolid, Spain.

Cancers
|October 16, 2025
PubMed
概括

一种新的全基NKG2DCAR-T细胞疗法针对多个瘤配体,克服了当前自身治疗方法的局限性. 用IL-7/IL-15/IL-21进行优化制造,可以为广泛的癌症治疗提供优质的CAR-T细胞.